US Stock MarketDetailed Quotes

Supernus Pharmaceuticals (SUPN)

Watchlist
  • 51.390
  • +2.170+4.41%
Close Apr 17 16:00 ET
  • 51.376
  • -0.014-0.03%
Post 20:01 ET
2.96BMarket Cap-75.57P/E (TTM)

Supernus Pharmaceuticals (SUPN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
8.63%718.95M
21.48%211.57M
9.34%192.1M
-1.71%165.45M
4.30%149.82M
8.94%661.82M
5.99%174.16M
14.17%175.69M
24.17%168.33M
-6.58%143.64M
Operating revenue
8.63%718.95M
21.48%211.57M
9.34%192.1M
-1.71%165.45M
4.30%149.82M
8.94%661.82M
5.99%174.16M
14.17%175.69M
24.17%168.33M
-6.58%143.64M
Cost of revenue
-4.29%74.56M
-11.84%23.01M
7.86%18.97M
-6.08%16.83M
-3.35%15.76M
-7.01%77.91M
32.97%26.1M
-10.30%17.58M
-15.05%17.92M
-30.48%16.31M
Gross profit
10.36%644.39M
27.36%188.57M
9.51%173.14M
-1.19%148.63M
5.28%134.06M
11.49%583.91M
2.33%148.06M
17.74%158.11M
31.39%150.41M
-2.28%127.34M
Operating expense
34.01%681.25M
38.36%174.74M
97.31%233.37M
3.25%136.49M
3.86%136.66M
-0.39%508.36M
0.48%126.3M
-6.57%118.28M
0.71%132.2M
3.79%131.58M
Selling and administrative expenses
50.99%485.56M
54.13%122.39M
157.59%179.68M
8.90%93.55M
3.96%89.94M
-4.39%321.58M
-2.30%79.41M
-15.66%69.75M
-1.01%85.9M
1.07%86.52M
-Selling and marketing expense
27.00%288.65M
52.37%83.19M
41.84%77.06M
10.76%65.13M
6.23%63.28M
-0.83%227.29M
-1.24%54.59M
-4.33%54.33M
-1.82%58.8M
4.08%59.57M
-General and administrative expense
108.84%196.91M
57.98%39.21M
565.33%102.62M
4.87%28.42M
-1.05%26.67M
-12.02%94.29M
-4.57%24.82M
-40.48%15.42M
0.79%27.1M
-5.00%26.95M
Research and development costs
-2.35%106.24M
-2.86%27.83M
1.14%29.37M
-15.54%22.12M
8.01%26.93M
18.78%108.8M
22.70%28.65M
28.17%29.04M
7.40%26.18M
17.53%24.93M
Depreciation amortization depletion
14.72%89.46M
34.43%24.53M
24.82%24.33M
3.54%20.82M
-1.74%19.79M
-5.35%77.98M
-13.41%18.24M
-8.26%19.49M
0.00%20.11M
0.86%20.14M
-Depreciation and amortization
14.72%89.46M
34.43%24.53M
24.82%24.33M
3.54%20.82M
-1.74%19.79M
-5.35%77.98M
-13.41%18.24M
-8.26%19.49M
0.00%20.11M
0.86%20.14M
Operating profit
-148.79%-36.86M
-36.48%13.82M
-251.22%-60.23M
-33.34%12.14M
38.89%-2.6M
463.72%75.56M
14.60%21.76M
418.47%39.83M
208.44%18.21M
-220.37%-4.25M
Net non-operating interest income expense
-18.21%13.25M
-59.35%2.02M
-44.44%2.28M
21.30%4.53M
30.30%4.43M
101.59%16.2M
150.60%4.98M
134.04%4.1M
711.52%3.73M
-11.59%3.4M
Non-operating interest income
-18.21%13.25M
-59.35%2.02M
-44.44%2.28M
21.30%4.53M
30.30%4.43M
55.02%16.2M
150.60%4.98M
134.04%4.1M
172.48%3.73M
-36.48%3.4M
Non-operating interest expense
--0
----
----
----
----
--0
--0
--0
--0
--0
Other net income (expense)
-516.02%-25.42M
-4,888.48%-17.76M
-799.54%-7.66M
132.72%6.11M
98.22%-356K
122.81%1.02M
651.27%4.36M
-33.52%1.1M
Special income (charges)
-516.02%-25.42M
-4,888.48%-17.76M
--0
--0
-799.54%-7.66M
132.72%6.11M
98.22%-356K
122.81%1.02M
651.27%4.36M
-33.52%1.1M
-Less:Restructuring and merger&acquisition
516.02%25.42M
4,888.48%17.76M
--0
--0
799.54%7.66M
-302.77%-6.11M
274.51%356K
-122.81%-1.02M
-651.27%-4.36M
33.52%-1.1M
-Less:Impairment of capital assets
--0
----
----
----
----
--0
----
----
----
----
Income before tax
-150.10%-49.03M
-107.25%-1.91M
-228.95%-57.95M
-36.62%16.67M
-2,499.59%-5.83M
3,434.49%97.87M
2,564.85%26.38M
354.47%44.94M
253.57%26.3M
-97.31%243K
Income tax
-143.66%-10.48M
-80.18%2.19M
-299.15%-12.84M
-191.29%-5.83M
4,938.66%6M
1,552.10%24.01M
6,075.14%11.05M
-75.08%6.45M
139.19%6.39M
101.50%119K
Net income
-152.19%-38.55M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
Net income continuous Operations
-152.19%-38.55M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
Minority interest income
Net income attributable to the parent company
-152.19%-38.55M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-152.19%-38.55M
-126.78%-4.11M
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
Basic earnings per share
-150.75%-0.68
-125.00%-0.07
-214.29%-0.8
11.11%0.4
-0.21
6,600.00%1.34
1,507.99%0.28
341.38%0.7
1,900.00%0.36
0
Diluted earnings per share
-151.52%-0.68
-125.93%-0.07
-215.94%-0.8
11.11%0.4
-0.21
6,500.00%1.32
1,450.57%0.27
337.93%0.69
1,900.00%0.36
0
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 8.63%718.95M21.48%211.57M9.34%192.1M-1.71%165.45M4.30%149.82M8.94%661.82M5.99%174.16M14.17%175.69M24.17%168.33M-6.58%143.64M
Operating revenue 8.63%718.95M21.48%211.57M9.34%192.1M-1.71%165.45M4.30%149.82M8.94%661.82M5.99%174.16M14.17%175.69M24.17%168.33M-6.58%143.64M
Cost of revenue -4.29%74.56M-11.84%23.01M7.86%18.97M-6.08%16.83M-3.35%15.76M-7.01%77.91M32.97%26.1M-10.30%17.58M-15.05%17.92M-30.48%16.31M
Gross profit 10.36%644.39M27.36%188.57M9.51%173.14M-1.19%148.63M5.28%134.06M11.49%583.91M2.33%148.06M17.74%158.11M31.39%150.41M-2.28%127.34M
Operating expense 34.01%681.25M38.36%174.74M97.31%233.37M3.25%136.49M3.86%136.66M-0.39%508.36M0.48%126.3M-6.57%118.28M0.71%132.2M3.79%131.58M
Selling and administrative expenses 50.99%485.56M54.13%122.39M157.59%179.68M8.90%93.55M3.96%89.94M-4.39%321.58M-2.30%79.41M-15.66%69.75M-1.01%85.9M1.07%86.52M
-Selling and marketing expense 27.00%288.65M52.37%83.19M41.84%77.06M10.76%65.13M6.23%63.28M-0.83%227.29M-1.24%54.59M-4.33%54.33M-1.82%58.8M4.08%59.57M
-General and administrative expense 108.84%196.91M57.98%39.21M565.33%102.62M4.87%28.42M-1.05%26.67M-12.02%94.29M-4.57%24.82M-40.48%15.42M0.79%27.1M-5.00%26.95M
Research and development costs -2.35%106.24M-2.86%27.83M1.14%29.37M-15.54%22.12M8.01%26.93M18.78%108.8M22.70%28.65M28.17%29.04M7.40%26.18M17.53%24.93M
Depreciation amortization depletion 14.72%89.46M34.43%24.53M24.82%24.33M3.54%20.82M-1.74%19.79M-5.35%77.98M-13.41%18.24M-8.26%19.49M0.00%20.11M0.86%20.14M
-Depreciation and amortization 14.72%89.46M34.43%24.53M24.82%24.33M3.54%20.82M-1.74%19.79M-5.35%77.98M-13.41%18.24M-8.26%19.49M0.00%20.11M0.86%20.14M
Operating profit -148.79%-36.86M-36.48%13.82M-251.22%-60.23M-33.34%12.14M38.89%-2.6M463.72%75.56M14.60%21.76M418.47%39.83M208.44%18.21M-220.37%-4.25M
Net non-operating interest income expense -18.21%13.25M-59.35%2.02M-44.44%2.28M21.30%4.53M30.30%4.43M101.59%16.2M150.60%4.98M134.04%4.1M711.52%3.73M-11.59%3.4M
Non-operating interest income -18.21%13.25M-59.35%2.02M-44.44%2.28M21.30%4.53M30.30%4.43M55.02%16.2M150.60%4.98M134.04%4.1M172.48%3.73M-36.48%3.4M
Non-operating interest expense --0------------------0--0--0--0--0
Other net income (expense) -516.02%-25.42M-4,888.48%-17.76M-799.54%-7.66M132.72%6.11M98.22%-356K122.81%1.02M651.27%4.36M-33.52%1.1M
Special income (charges) -516.02%-25.42M-4,888.48%-17.76M--0--0-799.54%-7.66M132.72%6.11M98.22%-356K122.81%1.02M651.27%4.36M-33.52%1.1M
-Less:Restructuring and merger&acquisition 516.02%25.42M4,888.48%17.76M--0--0799.54%7.66M-302.77%-6.11M274.51%356K-122.81%-1.02M-651.27%-4.36M33.52%-1.1M
-Less:Impairment of capital assets --0------------------0----------------
Income before tax -150.10%-49.03M-107.25%-1.91M-228.95%-57.95M-36.62%16.67M-2,499.59%-5.83M3,434.49%97.87M2,564.85%26.38M354.47%44.94M253.57%26.3M-97.31%243K
Income tax -143.66%-10.48M-80.18%2.19M-299.15%-12.84M-191.29%-5.83M4,938.66%6M1,552.10%24.01M6,075.14%11.05M-75.08%6.45M139.19%6.39M101.50%119K
Net income -152.19%-38.55M-126.78%-4.11M-217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K
Net income continuous Operations -152.19%-38.55M-126.78%-4.11M-217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K
Minority interest income
Net income attributable to the parent company -152.19%-38.55M-126.78%-4.11M-217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -152.19%-38.55M-126.78%-4.11M-217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K
Basic earnings per share -150.75%-0.68-125.00%-0.07-214.29%-0.811.11%0.4-0.216,600.00%1.341,507.99%0.28341.38%0.71,900.00%0.360
Diluted earnings per share -151.52%-0.68-125.93%-0.07-215.94%-0.811.11%0.4-0.216,500.00%1.321,450.57%0.27337.93%0.691,900.00%0.360
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More